Through the alteration of physiological reactions necessary for efficient stress management, ANS abnormalities may contribute to increased pain and other clinical issues related to fibromyalgia (e.g., increases in blood pressure) and pain inhibition via diminished production of growth hormone (GH) and insulin-like growth factor (IGF-1) [26,27]. The gene discussed is GH1; the disease is fibromyalgia.